VX1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vertex Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 494.5 EUR -0.47% Market Closed

Market Cap: €59.1B

V	Vertex Pharmaceuticals Inc XMUN:VX1	US
	Astellas Pharma Inc F:YPHA	JP
	Caisse Regionale de Credit Agricole Mutuel de Normandie Seine SC PAR:CCN	FR
V	Vertex Pharmaceuticals Inc F:VX1	US
J	Japan Post Bank Co Ltd F:5JP	JP
	Anadolu Efes Biracilik ve Malt Sanayii AS F:EF41	TR
P	Prinsiri PCL SET:PRIN	TH
	Lifecore Biomedical Inc F:LDE	US
S	Shin-Etsu Chemical Co Ltd XMUN:SEH	JP

Profitability Summary

Vertex Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

86%

Declining Gross Margin

88% > 86%

Exceptional Operating Margin

38%

Strong 3Y Average Operating Margin

40%

Declining Operating Margin

46% > 38%

Exceptional Net Margin

31%

Sustainable 3Y Average Net Margin

21%

Declining Net Margin

36% > 31%

Exceptional Free Cash Flow Margin

29%

Strong 3Y Average Free Cash Flow Margin

16%

Declining Free Cash Flow Margin

44% > 29%

Positive ROE

21%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.